Log In
Print
BCIQ
Print
Print this Print this
 

Intuniv, guanfacine extended release, guanfacine hydrochloride (S-877503) (formerly Connexyn, SPD503)

Also known as: GXR

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAdrenergic receptor alpha 2a (ADRA2A) agonist
Molecular Target Adrenergic receptor alpha 2a (ADRA2A)
Mechanism of ActionAdrenoceptor alpha 2a agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD); Treat attention deficit hyperactivity disorder (ADHD) in adolescents age 6-17; Treat attention deficit hyperactivity disorder (ADHD) in children who exhibit oppositional behavior
Regulatory Designation

EU - Standard Review (Treat attention deficit hyperactivity disorder (ADHD) in adolescents age 6-17)

Partner

Shionogi & Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today